Co-Diagnostics, Inc. (NASDAQ:CODX) said it will be presenting virtually this week at the 28th International Biodetection Technologies Conference, as well as hosting a virtual booth at the 65th Annual Caribbean Public Health Agency (CARPHA) Health Research Conference.
The International Biodetection Technologies Conference is being held on June 18, 2021. Co-Diagnostics’ presentation at 12.30pm ET will include a discussion of its point-of-care and at-home rapid PCR diagnostics platform currently in development, as the platform relates to supporting sample-to-result coronavirus (COVID-19) testing initiatives at the places where interactions take place to help normalize work, school, home and travel routines.
The presentation will also provide insight into aspects of the underlying CoPrimer technology and the results of the company’s analysis relative to global strains and variants of SARS-CoV-2.
READ: Co-Diagnostics turns 1Q net profit of nearly $8M on strong sales of its Logix Smart COVID-19 Test
The theme for the 2021 virtual CARPHA Health Research Conference, being held June 16-19, 2021, is 'Pandemic, NCDs and Climate Change: The Caribbean’s Triple Threat.'
Co-Diagnostics has been attending the CARPHA conference since 2016, and its virtual booth will present CoDiagnostics’ infectious disease and vector control products to conference attendees.
To learn more about the two conferences, including registration details, investors can visit: biodetectiontechnologies.com/point-of-care-diagnostics and carphaconference.vfairs.com
An archived version of the Biodetection Technologies presentation can be accessed on the Events and Webcasts section of the Co-Diagnostics website following the conclusion of the conference.
Contact the author at jon.hopkins@proactiveinvestors.com